Amino Acids (AA)

For-Met-Leu-Phe-OMe is a drug that has been shown to have anti-inflammatory properties in human cells. For-Met-Leu-Phe-OMe inhibits the production of inflammatory molecules, such as gamma-aminobutyric acid, and it also blocks the binding of leukotrienes to their receptors. These effects are due to its conformational properties, which allow it to bind to the receptor site and inhibit the binding of other molecules. For-Met-Leu-Phe-OMe has been shown to enhance the release of nucleotide levels and intracellular calcium concentration in vitro. It also binds to receptors on cells, which may be due to its biochemical properties or its analogues with other drugs.

Z-Gly-Pro-bNA is a peptide that has been synthesized using recombinant DNA technology. It is a carboxyl peptidase inhibitor, which inhibits the enzyme aspartic proteases and metalloendopeptidases. Z-Gly-Pro-bNA has a specific substrate, namely tetrathionate, and it is efficient in hydrolyzing carboxyl groups. This inhibition of the catalytic activity of these enzymes leads to an increase in proline and calcitonin levels. The optimum pH for this reaction is 8.5 to 9.5 and the optimum concentration is 50 to 300 μM.

Fmoc-glu(otbu)-thr(psi(Me,Me)pro)-OH is a c1-6 alkoxy, expressed, alkenyl, linker, c1-6 alkyl, efficiency, sequence that can be used for peptide synthesis. It is an efficient linker for the synthesis of peptides and has been shown to yield high yields with few side products. The hydroxyl group on the side chain of the amino acid residue provides an additional site for acylation. This product also contains an aralkyl and alkoxy group that can be used in further reactions.

Cyanoac-Phe-Phe-OH is a hydrolytic enzyme that irreversibly inactivates the ACE enzyme. It acts as an inhibitor of angiotensin-converting enzyme and inhibits the conversion of angiotensin I to angiotensin II, which is involved in blood pressure regulation. Cyanoac-Phe-Phe-OH has been shown to be more potent than captopril, another ACE inhibitor. It also has a longer half life and greater selectivity for ACE over other serine proteases.

4-Bromo-2-methylthiophene is a linker that is used in the synthesis of metal carbonyls. It has been shown to be an efficient cross-linking agent for the preparation of polymers. 4-Bromo-2-methylthiophene can be isomerized to 2,5-dimethylthiophene by heating it with hydroxylamine. 4-Bromo-2-methylthiophene can also catalyze the alkylation of nucleophiles such as ammonia and dimethyl sulfate, as well as nucleophilic attack on carboxylic acid derivatives. This compound is acidic, due to its chloride substituent, which can react with basic groups such as hydroxyl groups or amines.

Please enquire for more information about H-Lys-Gly-Gly-Lys-OH acetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

L-Cystine dihydrochloride is a chemical compound that is used as an amino acid. It has biological properties that are due to its ability to inhibit pancreatic lipase and l-threonine. L-Cystine dihydrochloride has been shown to have anti-infectious effects against a number of bacterial and viral diseases, including HIV, herpes simplex virus, and influenza. L-Cystine dihydrochloride is also used in cell culture experiments because it can be used to break disulfide bonds in proteins.

Please enquire for more information about Fmoc-α-methyl-L-phenylalanine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (Thr28, Nle 31)-Cholecystokinin-33 (25-33) (sulfated) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Hymenistatin I is a cyclic peptide that is synthesized from the natural amino acid L-proline. It has been shown to inhibit tumor growth and is used in the treatment of bladder cancer. The synthesis of Hymenistatin I begins with the protection of proline as an N-tert-butyloxycarbonyl derivative, followed by a sequence of coupling reactions. This synthetic process involves the use of a linker, such as tetrazole or succinimidyl ester, for example. The final product can then be purified by HPLC analysis. Hymenistatin I inhibits calcineurin inhibitor, which are immunosuppressive agents that are used to treat lymphocytic leukemia and other autoimmune diseases.

Hydrin 2 is a member of the family of peptide hormones that are involved in the regulation of blood pressure. It is synthesized from two amino acids, H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-. Hydrin 2 has been shown to have biological properties that are similar to those of angiotensin II and vasopressin. This peptide hormone is produced as a result of the action of hydrochloric acid on the precursor peptide, which is synthesized in the ventral and apical regions of the bladder. The reaction product is soluble in water and has been shown to be effective at treating wastewater.

Please enquire for more information about Cholecystokinin-33 (10-20) (bovine, porcine) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Phenylacetyl-(D-Arg2·28,p-chloro-Phe6,Arg9, Abu 15, Nle 27, Homoarg 29)-GRF (1-29) amide (human) including the price, delivery time and more detailed product information at the technical inquiry form on this page

The hormone LHRH is a decapeptide that stimulates the production of gonadotropins, which stimulate the synthesis and release of sex hormones. LHRH has been used for the treatment of prostate cancer. It can be administered in the form of a long-acting ester formulation, such as the pamoate salt (Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly), or as an analog, such as triptorelin acetate. The analogs are more potent than LHRH and have greater efficacy in preventing tumor growth and inducing regression. Analogs may be administered in microcapsules for extended release or orally to provide higher levels of drug at target sites. The ester linkages between amino acids allow for a sustained release of LHRH over time. These esters are hydrolyzed by enzymes present in plasma and tissues, releasing active LHRH into circulation that binds

Fmoc-Phe-Arg-OH is a peptide ligand that is able to bind to the receptor on osteoblasts, which are cells in bones. This binding triggers a cascade of events leading to the production of an extracellular matrix that provides structural support for the bone. The hydrogel used in this study consists of Fmoc-Phe-Arg-OH and a collagen backbone. It has been shown that Fmoc-Phe-Arg-OH can increase the proliferation rate of osteoblast cells in vitro when used with a collagen matrix. This may be due to its ability to induce cell differentiation and stimulate protein synthesis by binding to the receptor on osteoblasts.

Please enquire for more information about (Des-Gly10,D-Trp3,D-Leu6,Pro-NHEt 9)-LHRH trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page